| BACHEM HLDG NA SF 0,01 |
| Schweiz |
| Gesundheit |
| CH1176493729 / A3DLKE |
| BHM0 (Frankfurt) |
| FRA:BHM0, ETR:BHM0, BHM0:GR |
| - |
| https://www.bachem.com/ |
|
Bachem Holding AG is a Swiss biotechnology company specializing in the development and manufacturing of peptides and oligonucleotides for research, clinical development, and commercial applications. Founded in 1971 by Peter Grogg as Bachem Feinchemik..
>Volltext.. |
| 5701.51 Mio. EUR |
| 5729.9 Mio. EUR |
| 769.02 Mio. EUR |
| 210.08 Mio. EUR |
| 164.62 Mio. EUR |
| 2.2 EUR |
| 63.5 Mio. EUR |
| 34.29 Mio. EUR |
| 300.23 Mio. EUR |
| 0.08 |
| 15.96% |
| 24.94% |
| 0.98 EUR |
| 1.28% |
| 1.28% |
| 04.05.26 - 0.98217€ 21.04.23 - 0.810825€ >weitere anzeigen... |
| - |
| BACHEM |
| 22.07.26 |
|
||||
|